Epitinib (HMPL-813) is a selective, orally active, blood-brain barrier-permeable EGFR tyrosine kinase inhibitor. Epitinib is applicable to research on EGFRT790M-positive non-small cell lung cancer with brain metastasis and advanced solid tumors[1][2].
Molecular Weight:
430.50
Purity:
99.95
CAS Number:
[1203902-67-3]
Formula:
C24H26N6O2
Target:
EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
